ESfEQA – European Society for External Quality Assessment
ESfEQA offers a wide range of External Quality Assessment Schemes
ESfEQA was founded in Heidelberg/Germany in 2013 and is accredited according to the international standard ISO 17043:2010 by the German national accreditation body DAkkS.
Since its foundation, ESfEQA has expanded its program portfolio and at the same time the number of laboratories participating in ESfEQA’s external quality assessment schemes.
Currently, ESfEQA offers more than 70 quantitative and qualitative EQA schemes worldwide for your medical laboratory in the areas of:
Biochemistry
Immunology
Microbiology
Molecular Diagnostics
Haematology
Clinical Case Study Program
Participants submit their results to the ESfEQA database via the secured TEQA web application. ESfEQA evaluates the participants’ results according to ISO 13528 and provides the reports to the participants via TEQA.
ESfEQA – European Society for External Quality Assessment – offers a wide range of EQA programs for your medical laboratory in the areas of Biochemistry, Immunology, Microbiology, Molecular Diagnostics and Haematology.
- Increase your confidence and the confidence of customers and patients in your diagnostic results
- Benefit from peer group comparison and comparison with other diagnostic equipment
- Maintain a high-quality level to avoid costly and time consuming retesting
- Support the laboratory staff and management in their efforts for continuous quality improvement
Blood Gas and Electrolytes
Cardiac Marker
Cerebrospinal Fluid
Clinical Chemistry
Coagulation
Drugs of Abuse
Ethanol
Fecal Occult Blood
Glycated Hemoglobin
Qualitative Urine Analysis
Therapeutic Drugs
Urine Chemistry
Urine Sediments
hCG
Hormones
Procalcitonin
Specific Proteins
Tumor Marker
Adenovirus
Aspergillus Fumigatus
Bacteriology (Pathogen Identification and Antimicrobial Susceptibility Testing according to EUCAST and CLSI)
Borrelia
Brucella
Chagas
Chlamydophila Pneumoniae
Chlamydophila Trachomatis
Chikungunya Virus
Coxsackie-virus
Dengue Virus
ECHO Virus
Enterovirus
Epstein-Barr Virus
Hepatitis A Virus
Hepatitis B Virus
Hepatitis E Virus
HTLV I/II
Infectious Disease (HIV, HCV, HBV)
Influenza A Virus
Influenza B Virus
Leptospira
Malaria Microscopy (Parasite/Stage Identification)
Measles
Mosquito Transmitted Diseases (Chikungunya, West-Nile, Zika, Dengue)
Parainfluenza Virus
Parvovirus B 19
Respiratory Syncytial Virus
SARS-CoV-2
Syphilis
ToRCH
Varicella Zoster Virus
West-Nile-Fever Virus
Zika Virus
Blood Grouping
Immunhematology
Erythrocyte Sedimentation Rate
Erythrocyte Sedimentation Rate for Alifax and Alcor devices
Hemogram
Hemogram including 3-part Diff.
HBV Molecular
HCV Molecular
HIV Molecular
SARS-CoV-2 Molecular
EDUCATIONAL PROGRAMS
Clinical Case Study
ESfEQA reports provide a comparison of laboratory results with other laboratories that use the same analytical system, in particular the same analytical device or reagent, but also provide detailed information for comparison to other analytical devices. We consider the comparison to other analytical devices, methods etc. to be very important since the medical interpretation of laboratory results is usually not associated to any particular instrument, method or reagent brand.
In addition to detailed information, ESfEQA reports contain a summary that allows participants to capture the laboratory performance at a glance.
The reports for quantitative analytes (e. g. in Clinical Chemistry, Hormones or Haematology) consist of several sections.
Participants receive the survey reports electronically as PDF-files via the TEQA web application. Reports from previous surveys are stored in the TEQA database so that participants can download them.